But what they failed to tell the public in December 2020, is that scientists proved the spike protein, of which the Covid-19 vaccines instructs your cells to manufacture millions of, crosses the blood-brain barrier with potentially devastating consequences such as the potential to cause strokes, Alzheimer’s disease, Parkinson’s disease, Multiple Sclerosis, and a range of autoimmune disorders.
While mRNA vaccines have been in development for years, they had never been used on a large scale in the general population prior to December 2020, when the Pfizer-BioNTech and Moderna COVID-19 vaccines were granted emergency use authorization by regulatory agencies.
This is in contrast to traditional vaccines, which typically use a weakened or inactivated form of a virus to trigger an immune response. Traditional vaccines have been used for many decades and have an alleged long track record of safety and efficacy.
The main factor that contributed to the delayed use of mRNA vaccines on a large scale prior to December 2020 is the risk of antibody-dependent enhancement (ADE).
ADE is a phenomenon where a previous infection or vaccination can lead to a more severe form of the disease upon subsequent exposure. In the case of COVID-19, there were concerns that vaccination with an mRNA vaccine could trigger ADE and make the disease worse in people who were vaccinated.
Despite this, the Pfizer-BioNTech COVID-19 vaccine, an mRNA injection that is supposedly designed to provide protection against the alleged SARS-CoV-2 virus, which causes COVID-19, was granted Emergency Use Authorisation (EUA) in early December 2020.
The injection works by using a small piece of the alleged virus’s genetic material, known as messenger RNA (mRNA), which instructs cells in your body to produce a piece of the virus called the spike (S) protein.
The spike protein then triggers an immune response, which teaches the immune system to recognize and fight the alleged virus if a person is later exposed to it.
However, just days after the Pfizer vaccine was granted Emergency Use Authorisation, several scientists published a study, on the 16th of December 2020, proving the S protein of SARS-CoV-2 crosses the blood-brain barrier in mice...<<<Read More>>>...
